 |
|
|
| |
Characterization of Changes in Noninvasive Fibrosis Markers Over 8 Years of Tenofovir-Based Treatment in Patients With Chronic Hepatitis B Enrolled in Two Phase 3 Trials
|
| |
| |
AASLD Nov 15-19 2024 San Diego, CA
Laurent Castera1, Ming-Lung Yu2, Maria Buti3,4, Jin Lin Hou5, Frida Abramov6, Hongyuan Wang6, Ben L Da6, Dana Tedesco6, Leland J Yee6, John F Flaherty6, Harry Janssen7,8, Milan J Sonneveld8
|
| |
|
|
|
|
|
